-
Potential impact of obesity on the aggressiveness of low- to intermediate-risk papillary thyroid carcinoma: results from a MASTER cohort study.
Kim M, Kang YE, Park YJ, Koo BS, Ku EJ, Choi JY, Lee EK, Kim BH.
2023 Jul 29
Endocrine. 2023 Jul 29. doi: 10.1007/s12020-023-03416-5. Online ahead of print.
-
Inflammatory biomarkers predict outcomes of patients with radioactive iodine refractory thyroid cancer treated with sorafenib.
Jin M, Kim M, Jeon MJ, Kim EY, Shin DY, Kim BH, Kim WB, Shong YK, Lim DJ, Kim WG.
2023 Aug
Endocrine. 2023 Aug;81(2):298-305.
-
Survey of Korean head and neck surgeons and endocrinologists for the surgical extent of 1.5 and 2.5 cm papillary thyroid carcinoma.
Cheon YI, Shin SC, Lee M, Sung ES, Lee JC, Kim M, Kim BH, Kim IJ, Lee BJ.
2022 Nov
Gland Surg. 2022 Nov;11(11):1744-1753.
-
Heart Failure and Stroke Risks in Users of Liothyronine With or Without Levothyroxine Compared with Levothyroxine Alone: A Propensity Score-Matched Analysis.
Yi W, Kim BH, Kim M, Kim J, Im M, Ryang S, Kim EH, Jeon YK, Kim SS, Kim IJ.
2022 Jul
Thyroid. 2022 Jul;32(7):764-771.
-
Lenvatinib Compared with Sorafenib as a First-Line Treatment for Radioactive Iodine-Refractory, Progressive, Differentiated Thyroid Carcinoma: Real-World Outcomes in a Multicenter Retrospective Cohort Study.
Kim M, Jin M, Jeon MJ, Kim EY, Shin DY, Lim DJ, Kim BH, Kang HC, Kim WB, Shong YK, Kim HK, Kim WG.
2022 May
Thyroid. 2023 Jan;33(1):91-99. doi: 10.1089/thy.2022.0054. Epub 2022 May 17.
-
Risk factors for second primary malignancies following thyroid cancer: a nationwide cohort study.
Kim M, Kim H, Park S, Joo J, Kim IJ, Kim BH.
2022 Apr
Eur J Endocrinol. 2022 Apr 1;186(5):561-571.
-
Association between visceral adipose tissue volume, measured using computed tomography, and cardio-metabolic risk factors.
Yi W, Kim K, Im M, Ryang S, Kim EH, Kim M, Jeon YK, Kim SS, Kim BH, Pak K, Kim IJ, Kim SJ.
2022 Jan
Sci Rep. 2022 Jan 10;12(1):387.
-
Investigation of attachment location of adhesive skin electrodes for intraoperative neuromonitoring in thyroid surgery: Preclinical and clinical studies.
Shin SC, Sung ES, Kwon HK, Cheon YI, Lee M, Lee JC, Kim BH, Kim IJ, Lee BJ.
2022 Feb
Surgery. 2022 Feb;171(2):377-383
-
Clinical Characteristics and Prognosis of Coexisting Thyroid Cancer in Patients with Graves' Disease: A Retrospective Multicenter Study.
Yoon JH, Jin M, Kim M, Hong AR, Kim HK, Kim BH, Kim WB, Shong YK, Jeon MJ, Kang HC.
2021 Dec
Endocrinol Metab (Seoul). 2021 Dec;36(6):1268-1276.
-
Whole-Exome Sequencing in Papillary Microcarcinoma: Potential Early Biomarkers of Lateral Lymph Node Metastasis.
Kim M, Kwon CH, Jang MH, Kim JM, Kim EH, Jeon YK, Kim SS, Choi KU, Kim IJ, Park M, Kim BH.
2021 Oct
Endocrinol Metab (Seoul). 2021 Oct;36(5):1086-1094
-
Clinicopathological Characteristics and Disease-Free Survival in Patients with Hürthle Cell Carcinoma: A Multicenter Cohort Study in South Korea.
Jin M, Kim ES, Kim BH, Kim HK, Kang YE, Jeon MJ, Kim TY, Kang HC, Kim WB, Shong YK, Kim M, Kim WG.
2021 Oct
Endocrinol Metab (Seoul). 2021 Oct;36(5):1078-1085
-
Comparison of Thyroid Imaging Reporting and Data Systems in Malignancy Risk Stratification of Indeterminate Thyroid Nodules.
Kim BH.
2021 Oct
Endocrinol Metab (Seoul). 2021 Oct;36(5):974-976.
-
The Concept of Economic Evaluation and Its Application in Thyroid Cancer Research.
Kim K, Kim M, Lim W, Kim BH, Park SK.
2021 Aug
Endocrinol Metab (Seoul). 2021 Aug;36(4):725-736.
-
Current Guidelines for Management of Medullary Thyroid Carcinoma.
Kim M, Kim BH.
2021 Jun
Endocrinol Metab (Seoul). 2021 Jun;36(3):514-524.
-
Clinicopathological Characteristics and Recurrence-Free Survival of Rare Variants of Papillary Thyroid Carcinomas in Korea: A Retrospective Study.
Kim M, Cho SW, Park YJ, Ahn HY, Kim HS, Suh YJ, Choi D, Kim BK, Yang GE, Park IS, Yi KH, Jung CK, Kim BH.
2021 Jun
Endocrinol Metab (Seoul). 2021 Jun;36(3):619-627
-
A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol.
Lee EK, Kang YE, Park YJ, Koo BS, Chung KW, Ku EJ, Won HR, Yoo WS, Jeon E, Paek SH, Lee YS, Lim DM, Suh YJ, Park HK, Kim HJ, Kim BH, Kim M, Kim SW, Yi KH, Park SK, Jung EJ, Choi JY, Bae JS, Hong JH, Nam KH, Lee YK, Yu HW, Go S, Kang YM; MASTER study group.
2021 Jun
Endocrinol Metab (Seoul). 2021 Jun;36(3):574-581.
-
The longer the antithyroid drug is used, the lower the relapse rate in Graves' disease: a retrospective multicenter cohort study in Korea.
Park SY, Kim BH, Kim M, Hong AR, Park J, Park H, Choi MS, Kim TH, Kim SW, Kang HC, Chung JH.
2021 Oct
Endocrine. 2021 Oct;74(1):120-127.
-
Clinical outcomes of T4a papillary thyroid cancer with recurrent laryngeal nerve involvement: a retrospective analysis.
Na HS, Kwon HK, Shin SC, Cheon YI, Seo M, Lee JC, Sung ES, Lee M, Kim IJ, Kim BH, Lee BJ.
2021 Mar
Sci Rep. 2021 Mar 23;11(1):6707
-
Protocol for a Korean Multicenter Prospective Cohort Study of Active Surveillance or Surgery (KoMPASS) in Papillary Thyroid Microcarcinoma.
Jeon MJ, Kang YE, Moon JH, Lim DJ, Lee CY, Lee YS, Kim SW, Kim MH, Kim BH, Kang HC, Shong M, Cho SW, Kim WB.
2021 Apr
Endocrinol Metab (Seoul). 2021 Apr;36(2):359-364
-
코로나바이러스 감염병 19와 갑상선질환
김미진, 김보현
2021
Journal of Clinical Otolaryngology Head and Neck Surgery 2021;32:179-188
-
Real-world experience of lenvatinib in patients with advanced anaplastic thyroid cancer.
Kim M, Ahn J, Song DE, Yoon JH, Kang HC, Lim DJ, Kim WG, Kim TY, Kim WB, Shong YK, Jeon MJ, Kim BH.
2021 Feb
Endocrine. 2021 Feb;71(2):427-433. doi: 10.1007/s12020-020-02425-y. Epub 2020 Jul 29.
View PubMed
-
Thyroid cancer after hysterectomy and oophorectomy: a nationwide cohort study.
Kim M, Kim BH, Lee H, Nam H, Park S, Jang MH, Kim JM, Kim EH, Jeon YK, Kim SS, Kim IJ.
2021 Jan
Eur J Endocrinol. 2021 Jan;184(1):143-151. doi: 10.1530/EJE-20-0686.
View PubMed
-
Association between Serum Free Thyroxine and Anemia in Euthyroid Adults: A Nationwide Study.
Kim M, Kim BH, Lee H, Jang MH, Kim JM, Kim EH, Jeon YK, Kim SS, Kim IJ.
2020 Mar
Endocrinol Metab (Seoul). 2020 Mar;35(1):106-114. doi: 10.3803/EnM.2020.35.1.106.
View PubMed
-
Short-term bone marrow suppression in differentiated thyroid cancer patients after radioactive iodine treatment.
Yi W, Kim BH, Kim M, Ryang SR, Jang MH, Kim JM, Kim EH, Jeon YK, Kim SS, Kim IJ.
2020 Dec 28
Endocr J. 2020 Dec 28;67(12):1193-1198. doi: 10.1507/endocrj.EJ20-0242. Epub 2020 Jul 28.
View PubMed
-
Cerebral glucose metabolism differs according to future weight change.
Kim JM, Jang M, Kim EH, Kim M, Choi SJ, Kim K, Pak K, Jeon YK, Kim SS, Kim BH, Kim SJ, Kim IJ.
2020 Dec
Brain Imaging Behav. 2020 Dec;14(6):2295-2301. doi: 10.1007/s11682-019-00180-x.
View PubMed
-
Lymphocyte-to-monocyte ratio prior to radioiodine ablation in low- and intermediate-risk, papillary thyroid cancer.
Kim K, Pak K, Kim IJ, Kim M, Kim BH, Lee BJ, Kim SJ.
2020 Nov
Endocrine. 2020 Nov;70(2):364-371. doi: 10.1007/s12020-020-02328-y. Epub 2020 May 5.
View PubMed
-
Clinical Implication of World Health Organization Classification in Patients with Follicular Thyroid Carcinoma in South Korea: A Multicenter Cohort Study.
Jin M, Kim ES, Kim BH, Kim HK, Yi HS, Jeon MJ, Kim TY, Kang HC, Kim WB, Shong YK, Kim M, Kim WG.
2020 Sep
Endocrinol Metab (Seoul). 2020 Sep;35(3):618-627. doi: 10.3803/EnM.2020.742. Epub 2020 Sep 22.
View PubMed
-
Vandetanib for the Management of Advanced Medullary Thyroid Cancer: A Real-World Multicenter Experience.
Kim M, Yoon JH, Ahn J, Jeon MJ, Kim HK, Lim DJ, Kang HC, Kim IJ, Shong YK, Kim TY, Kim BH.
2020 Sep
Endocrinol Metab (Seoul). 2020 Sep;35(3):587-594. doi: 10.3803/EnM.2020.687. Epub 2020 Sep 22.
View PubMed
-
Arterial stiffness is an independent predictor for risk of mortality in patients with type 2 diabetes mellitus: the REBOUND study.
Kim JM, Kim SS, Kim IJ, Kim JH, Kim BH, Kim MK, Lee SH, Lee CW, Kim MC, Ahn JH, Kim J.
2020 Sep 22
Cardiovasc Diabetol. 2020 Sep 22;19(1):143. doi: 10.1186/s12933-020-01120-6.
View PubMed
-
Association between Serum Free Thyroxine and Anemia in Euthyroid Adults: A Nationwide Study (Endocrinol Metab 2020;35:106-14, Mijin Kim et al.).
Kim M, Kim BH.
2020 Sep
Endocrinol Metab (Seoul). 2020 Sep;35(3):669-670. doi: 10.3803/EnM.2020.306. Epub 2020 Jul 30.
View PubMed
-
Unusual metastases from differentiated thyroid cancers: A multicenter study in Korea.
Yoon JH, Jeon MJ, Kim M, Hong AR, Kim HK, Shin DY, Kim BH, Kim WB, Shong YK, Kang HC.
2020
PLoS One. 2020;15(8):e0238207. doi: 10.1371/journal.pone.0238207. eCollection 2020.
View PubMed
-
Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Candidate Biomarkers Associated with Survival: A Multicenter Study in Korea.
Song E, Kim M, Kim EY, Kim BH, Shin DY, Kang HC, Ahn BC, Kim WB, Shong YK, Jeon MJ, Lim DJ.
2020 May
Thyroid. 2020 May;30(5):732-738. doi: 10.1089/thy.2019.0476. Epub 2020 Feb 11.
View PubMed
-
Modification of the Tumor-Node-Metastasis Staging System for Differentiated Thyroid Carcinoma by Considering Extra-Thyroidal Extension and Lateral Cervical Lymph Node Metastasis.
Kim M, Kim WG, Jeon MJ, Kim HK, Yi HS, Kim ES, Kim BH, Kim WB, Shong YK, Kang HC, Kim TY.
2020 Mar
Endocrinol Metab (Seoul). 2020 Mar;35(1):149-156. doi: 10.3803/EnM.2020.35.1.149.
View PubMed
-
Anesthetic experience of frontotemporal dementia patient with severe autonomic dysfunction: a case report.
Kim HJ, Lee HJ, Lee DW, Kim JY, Kwon JY, Kim HK, Kim WS, Hwang BY.
2017 Jun
Korean J Anesthesiol. 2017 Jun;70(3):356-360. doi: 10.4097/kjae.2017.70.3.356. Epub 2017 Feb 3.
View PubMed